» Articles » PMID: 26599120

Osteoclastogenesis and Osteogenesis During Tooth Movement

Overview
Journal Front Oral Biol
Publisher Karger
Specialty Dentistry
Date 2015 Nov 25
PMID 26599120
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

It is a well-known concept that bone remodeling occurs during orthodontic tooth movement. The orthodontic literature is vastly full of information about the changes occurring on the periodontal ligament level. However, changes occurring in the alveolar bone are being elucidated. The purpose of this chapter is to present some of the studies describing the bone changes associated with orthodontic tooth movement. Initiation of osteoclastogenesis requires inflammation in the adjacent area. Tissue biomarker RANKL responds to the compressive forces. Conversely, an increase in osteoprotegrin biomarker causes a decrease in RANKL and inhibits tooth movement. Osteocyte activity during tooth movement is not well understood. Emerging studies are showing the effect of osteocytes on orthodontic tooth movement. Nitric oxide (NO), produced by osteocytes, is an important regulator of bone response to loading and has been shown to mediate osteoclast activity. iNOS (which produces NO) has been shown to mediate inflammation-induced bone resorption on the compression side. Several molecules have been linked to osteogenesis in tooth movement: TGF-β, BSP, BMPs and epidermal growth factor. Osteogenesis on the tension side is not well understood. Studies have shown increase in the expression of Runx2 on the tension side. Additionally, eNOS (produces NO) mediates bone formation on the tension side. The concept of osteoclastogenesis and osteogenesis is being unraveled.

Citing Articles

Challenges and Perspectives Regarding the Determination of Gingival Crevicular Fluid Biomarkers During Orthodontic Treatment: A Narrative Review.

Bud A, Lazar L, Martu M, Dako T, Suciu M, Vlasiu A Medicina (Kaunas). 2025; 60(12.

PMID: 39768884 PMC: 11728204. DOI: 10.3390/medicina60122004.


GPR40/GPR120 Agonist GW9508 Improves Metabolic Syndrome-Exacerbated Periodontitis in Mice.

Li Y, Yu H, Lopes-Virella M, Huang Y Int J Mol Sci. 2024; 25(17).

PMID: 39273569 PMC: 11394899. DOI: 10.3390/ijms25179622.


Selected osteointegration markers in different timeframes after dental implantation: findings and prognostic value.

Bayandurov E, Orjonikidze Z, Kraveishvili S, Orjonikidze R, Ormotsadze G, Kalmakhelidze S Acta Biochim Pol. 2024; 71:12433.

PMID: 38721304 PMC: 11077352. DOI: 10.3389/abp.2024.12433.


GDF15 Contributes to the Regulation of the Mechanosensitive Responses of PdL Fibroblasts through the Modulation of IL-37.

Steinmetz J, Stemmler A, Hennig C, Symmank J, Jacobs C Dent J (Basel). 2024; 12(2).

PMID: 38392243 PMC: 10888100. DOI: 10.3390/dj12020039.


Bevacizumab, a vascular endothelial growth factor inhibitor, promotes orthodontic tooth movement in an experimental rat model.

Abuohashish H, Alamri A, Shahin S, Almazrou D, Alkhamis T, Omar O Heliyon. 2023; 9(5):e16217.

PMID: 37215827 PMC: 10199243. DOI: 10.1016/j.heliyon.2023.e16217.